![]() ![]() Vaping products that do not contain nicotine come under the General Product Safety Regulations 2005, enforced by local authority trading standards. An analysis of notifications in 2016 to 2017 found that notified products were unlikely to cause serious harm. Vaping products containing nicotine are regulated under the Tobacco and Related Products Regulations 2016 ( TRPR), and need to be notified to the MHRA and comply to certain standards (for example, nicotine content is limited to 20 milligrams per millilitre (mg/mL)) before they can be legally sold in the UK. Here we summarise the main regulations in England governing vaping products and their surveillance, the Medicines and Healthcare products Regulatory Agency ( MHRA) safety monitoring, relevant government strategies and consultations, recent reports on regulations, the National Institute for Health and Care Excellence ( NICE) tobacco guideline, as well as selected international developments. These terms do not include cannabis vaping or the vaping of other legal or illegal substances, which are not the subject of this report. We use ‘vapers’ to refer to people who regularly use vaping products and ‘vaping’ as the act of using a vaping product. Where studies explored products without nicotine, we refer to them as non-nicotine vaping or vaping products. Some vaping products do not always contain nicotine. TerminologyĪs in our 20 reports, we use the term ‘vaping products’ to describe e-cigarettes and refill containers (e-liquids) intended for nicotine vaping. This may also help to understand underlying trends, given the influence of COVID-19 recently on the availability of data and on smoking and vaping behaviours. Throughout our report, we have also tried to reflect on changes in England since our first report in 2015. This Cochrane review examines the effectiveness of using electronic cigarettes to help people who smoke tobacco achieve long-term smoking abstinence and searches for updates of the evidence monthly. We have covered this topic in our previous report, and the Cochrane collaboration has an ongoing (updated monthly) systematic review on electronic cigarettes for smoking cessation. The evidence for the effectiveness of vaping to help people who smoke quit. This is because a new Cochrane review on electronic cigarettes and subsequent cigarette smoking in young people is examining the existing literature about this, among people under 30 years old. The relationship between vaping and subsequent smoking. We felt these issues were either being addressed comprehensively elsewhere or had been covered in our previous reports. Our report does not cover 2 important issues. It looks at the prevalence of heated tobacco product use in England, incorporating a summary of the latest Cochrane Review on heated tobacco products, and a new systematic review on harm perceptions of vaping products and interventions to affect perceptions. This report also covers the latest evidence on prevalence and characteristics of vaping in young people and adults in England, with a focus on the data emerging since our last report published in early 2021. biomarkers specifically associated with cancer, respiratory, cardiovascular or other health outcomes.biomarkers of potential harm to health cutting across several diseases, including cancer, respiratory and cardiovascular diseases.biomarkers of exposure to nicotine and potential toxicants.We carried out a systematic literature review of the health risks and health effects of vaping and divided the findings into chapters. This current report focuses predominantly on the potential health risks of vaping. the second most important risk factor for death and disability-adjusted life years globally.a leading cause of health inequalities in England.the largest single risk factor for death and years of life lived in ill-health globally.The series aims to summarise the evidence on vaping products and to inform policies and regulations.Īlternative nicotine delivery devices such as vaping products can play a vital role in reducing the huge health burden caused by cigarette smoking, which remains: This report is the eighth in a series of independent reports originally commissioned by Public Health England ( PHE) and now the Office for Health Improvement and Disparities (OHID) in the Department of Health and Social Care. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |